0.013053 0.007536 0.000000 0.000000 0.015073 0.000000 0.000000 0.000000 0.007418 0.000000 0.000000 0.000000 Joint Center for Structural Genomics (JCSG) http://mmcif.pdb.org/dictionaries/ascii/mmcif_pdbx.dic 6 90.000 90.000 120.000 76.609 76.609 134.815 C3 H7 N O2 89.093 y ALANINE L-peptide linking C6 H15 N4 O2 1 175.209 y ARGININE L-peptide linking C4 H8 N2 O3 132.118 y ASPARAGINE L-peptide linking C4 H7 N O4 133.103 y ASPARTIC ACID L-peptide linking C2 H6 O2 62.068 1,2-ETHANEDIOL ETHYLENE GLYCOL non-polymer C5 H10 N2 O3 146.144 y GLUTAMINE L-peptide linking C5 H9 N O4 147.129 y GLUTAMIC ACID L-peptide linking C2 H5 N O2 75.067 y GLYCINE peptide linking C6 H10 N3 O2 1 156.162 y HISTIDINE L-peptide linking H2 O 18.015 WATER non-polymer C6 H13 N O2 131.173 y ISOLEUCINE L-peptide linking C6 H13 N O2 131.173 y LEUCINE L-peptide linking C6 H15 N2 O2 1 147.195 y LYSINE L-peptide linking C5 H11 N O2 Se 196.106 n SELENOMETHIONINE L-peptide linking C9 H11 N O2 165.189 y PHENYLALANINE L-peptide linking C5 H9 N O2 115.130 y PROLINE L-peptide linking C3 H7 N O3 105.093 y SERINE L-peptide linking C4 H9 N O3 119.119 y THREONINE L-peptide linking C11 H12 N2 O2 204.225 y TRYPTOPHAN L-peptide linking C9 H11 N O3 181.189 y TYROSINE L-peptide linking C5 H11 N O2 117.146 y VALINE L-peptide linking To be published 0353 Crystal structure of Putative methyltransferase from antibiotic biosynthesis pathway (YP_324569.1) from ANABAENA VARIABILIS ATCC 29413 at 2.40 A resolution 10.2210/pdb3ege/pdb pdb_00003ege 100 1 Flat collimating mirror, toroid focusing mirror CCD 2008-08-11 MARMOSAIC 325 mm CCD Double crystal monochromator SINGLE WAVELENGTH M x-ray 1 0.97915 1.0 BL9-2 SSRL 0.97915 SYNCHROTRON SSRL BEAMLINE BL9-2 29883.744 Putative methyltransferase from antibiotic biosynthesis pathway 1 man polymer 62.068 1,2-ETHANEDIOL 1 syn non-polymer 18.015 water 124 nat water Putative MerR-family transcriptional regulator no yes G(MSE)SIYNSIGKQYSQTRVPDIRIVNAIINLLNLPKGSVIADIGAGTGGYSVALANQGLFVYAVEPSIV(MSE)RQQA VVHPQVEWFTGYAENLALPDKSVDGVISILAIHHFSHLEKSFQE(MSE)QRIIRDGTIVLLTFDIRLAQRIWLYDYFPFL WEDALRFLPLDEQINLLQENTKRRVEAIPFLLPHDLSDLFAAAAWRRPELYLKAEVRAGISSFALANQDLVEKGLELLTA DLNNGEWIRKYGEIHHLQEIDIGYRFIYTTLDK GMSIYNSIGKQYSQTRVPDIRIVNAIINLLNLPKGSVIADIGAGTGGYSVALANQGLFVYAVEPSIVMRQQAVVHPQVEW FTGYAENLALPDKSVDGVISILAIHHFSHLEKSFQEMQRIIRDGTIVLLTFDIRLAQRIWLYDYFPFLWEDALRFLPLDE QINLLQENTKRRVEAIPFLLPHDLSDLFAAAAWRRPELYLKAEVRAGISSFALANQDLVEKGLELLTADLNNGEWIRKYG EIHHLQEIDIGYRFIYTTLDK A 383250 polypeptide(L) n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n sample 29413 YP_324569.1, Ava_4070 240292 Anabaena variabilis ATCC 29413 562 Escherichia coli HK100 Plasmid SpeedET 1 3.82 67.81 VAPOR DIFFUSION, SITTING DROP 4.2 31.0% ethylene glycol, 0.1M phosphate-citrate pH 4.2, NANODROP, VAPOR DIFFUSION, SITTING DROP, temperature 277K 277 Joint Center for Structural Genomics JCSG PSI, Protein Structure Initiative software software struct_conn database_2 struct_ref_seq_dif struct_site repository Initial release Advisory Version format compliance Refinement description Data collection Derived calculations Refinement description Database references Derived calculations 1 0 2008-10-14 1 1 2011-07-13 1 2 2017-10-25 1 3 2019-07-24 1 4 2023-02-01 _software.classification _software.name _software.classification _software.contact_author _software.contact_author_email _software.language _software.location _software.name _software.type _software.version _struct_conn.pdbx_leaving_atom_flag _database_2.pdbx_DOI _database_2.pdbx_database_accession _struct_ref_seq_dif.details _struct_site.pdbx_auth_asym_id _struct_site.pdbx_auth_comp_id _struct_site.pdbx_auth_seq_id Y RCSB Y RCSB 2008-09-10 REL REL EDO 1,2-ETHANEDIOL HOH water THE CONSTRUCT WAS EXPRESSED WITH A PURIFICATION TAG MGSDKIHHHHHHENLYFQG. THE TAG WAS REMOVED WITH TEV PROTEASE LEAVING ONLY A GLYCINE (0) FOLLOWED BY THE TARGET SEQUENCE. EDO 1 2 EDO EDO 261 A HOH 2 3 HOH HOH 262 A HOH 3 3 HOH HOH 263 A HOH 4 3 HOH HOH 264 A HOH 5 3 HOH HOH 265 A HOH 6 3 HOH HOH 266 A HOH 7 3 HOH HOH 267 A HOH 8 3 HOH HOH 268 A HOH 9 3 HOH HOH 269 A HOH 10 3 HOH HOH 270 A HOH 11 3 HOH HOH 271 A HOH 12 3 HOH HOH 272 A HOH 13 3 HOH HOH 273 A HOH 14 3 HOH HOH 274 A HOH 15 3 HOH HOH 275 A HOH 16 3 HOH HOH 276 A HOH 17 3 HOH HOH 277 A HOH 18 3 HOH HOH 278 A HOH 19 3 HOH HOH 279 A HOH 20 3 HOH HOH 280 A HOH 21 3 HOH HOH 281 A HOH 22 3 HOH HOH 282 A HOH 23 3 HOH HOH 283 A HOH 24 3 HOH HOH 284 A HOH 25 3 HOH HOH 285 A HOH 26 3 HOH HOH 286 A HOH 27 3 HOH HOH 287 A HOH 28 3 HOH HOH 288 A HOH 29 3 HOH HOH 289 A HOH 30 3 HOH HOH 290 A HOH 31 3 HOH HOH 291 A HOH 32 3 HOH HOH 292 A HOH 33 3 HOH HOH 293 A HOH 34 3 HOH HOH 294 A HOH 35 3 HOH HOH 295 A HOH 36 3 HOH HOH 296 A HOH 37 3 HOH HOH 297 A HOH 38 3 HOH HOH 298 A HOH 39 3 HOH HOH 299 A HOH 40 3 HOH HOH 300 A HOH 41 3 HOH HOH 301 A HOH 42 3 HOH HOH 302 A HOH 43 3 HOH HOH 303 A HOH 44 3 HOH HOH 304 A HOH 45 3 HOH HOH 305 A HOH 46 3 HOH HOH 306 A HOH 47 3 HOH HOH 307 A HOH 48 3 HOH HOH 308 A HOH 49 3 HOH HOH 309 A HOH 50 3 HOH HOH 310 A HOH 51 3 HOH HOH 311 A HOH 52 3 HOH HOH 312 A HOH 53 3 HOH HOH 313 A HOH 54 3 HOH HOH 314 A HOH 55 3 HOH HOH 315 A HOH 56 3 HOH HOH 316 A HOH 57 3 HOH HOH 317 A HOH 58 3 HOH HOH 318 A HOH 59 3 HOH HOH 319 A HOH 60 3 HOH HOH 320 A HOH 61 3 HOH HOH 321 A HOH 62 3 HOH HOH 322 A HOH 63 3 HOH HOH 323 A HOH 64 3 HOH HOH 324 A HOH 65 3 HOH HOH 325 A HOH 66 3 HOH HOH 326 A HOH 67 3 HOH HOH 327 A HOH 68 3 HOH HOH 328 A HOH 69 3 HOH HOH 329 A HOH 70 3 HOH HOH 330 A HOH 71 3 HOH HOH 331 A HOH 72 3 HOH HOH 332 A HOH 73 3 HOH HOH 333 A HOH 74 3 HOH HOH 334 A HOH 75 3 HOH HOH 335 A HOH 76 3 HOH HOH 336 A HOH 77 3 HOH HOH 337 A HOH 78 3 HOH HOH 338 A HOH 79 3 HOH HOH 339 A HOH 80 3 HOH HOH 340 A HOH 81 3 HOH HOH 341 A HOH 82 3 HOH HOH 342 A HOH 83 3 HOH HOH 343 A HOH 84 3 HOH HOH 344 A HOH 85 3 HOH HOH 345 A HOH 86 3 HOH HOH 346 A HOH 87 3 HOH HOH 347 A HOH 88 3 HOH HOH 348 A HOH 89 3 HOH HOH 349 A HOH 90 3 HOH HOH 350 A HOH 91 3 HOH HOH 351 A HOH 92 3 HOH HOH 352 A HOH 93 3 HOH HOH 353 A HOH 94 3 HOH HOH 354 A HOH 95 3 HOH HOH 355 A HOH 96 3 HOH HOH 356 A HOH 97 3 HOH HOH 357 A HOH 98 3 HOH HOH 358 A HOH 99 3 HOH HOH 359 A HOH 100 3 HOH HOH 360 A HOH 101 3 HOH HOH 361 A HOH 102 3 HOH HOH 362 A HOH 103 3 HOH HOH 363 A HOH 104 3 HOH HOH 364 A HOH 105 3 HOH HOH 365 A HOH 106 3 HOH HOH 366 A HOH 107 3 HOH HOH 367 A HOH 108 3 HOH HOH 368 A HOH 109 3 HOH HOH 369 A HOH 110 3 HOH HOH 370 A HOH 111 3 HOH HOH 371 A HOH 112 3 HOH HOH 372 A HOH 113 3 HOH HOH 373 A HOH 114 3 HOH HOH 374 A HOH 115 3 HOH HOH 375 A HOH 116 3 HOH HOH 376 A HOH 117 3 HOH HOH 377 A HOH 118 3 HOH HOH 378 A HOH 119 3 HOH HOH 379 A HOH 120 3 HOH HOH 380 A HOH 121 3 HOH HOH 381 A HOH 122 3 HOH HOH 382 A HOH 123 3 HOH HOH 383 A HOH 124 3 HOH HOH 384 A HOH 125 3 HOH HOH 385 A n 1 0 A n 2 1 A n 3 2 A n 4 3 A n 5 4 A n 6 5 A n 7 6 A n 8 7 A n 9 8 A n 10 9 A n 11 10 A n 12 11 A SER 12 n 13 SER 12 A GLN 13 n 14 GLN 13 A THR 14 n 15 THR 14 A ARG 15 n 16 ARG 15 A VAL 16 n 17 VAL 16 A PRO 17 n 18 PRO 17 A ASP 18 n 19 ASP 18 A ILE 19 n 20 ILE 19 A ARG 20 n 21 ARG 20 A ILE 21 n 22 ILE 21 A VAL 22 n 23 VAL 22 A ASN 23 n 24 ASN 23 A ALA 24 n 25 ALA 24 A ILE 25 n 26 ILE 25 A ILE 26 n 27 ILE 26 A ASN 27 n 28 ASN 27 A LEU 28 n 29 LEU 28 A LEU 29 n 30 LEU 29 A ASN 30 n 31 ASN 30 A LEU 31 n 32 LEU 31 A PRO 32 n 33 PRO 32 A LYS 33 n 34 LYS 33 A GLY 34 n 35 GLY 34 A SER 35 n 36 SER 35 A VAL 36 n 37 VAL 36 A ILE 37 n 38 ILE 37 A ALA 38 n 39 ALA 38 A ASP 39 n 40 ASP 39 A ILE 40 n 41 ILE 40 A GLY 41 n 42 GLY 41 A ALA 42 n 43 ALA 42 A GLY 43 n 44 GLY 43 A THR 44 n 45 THR 44 A GLY 45 n 46 GLY 45 A GLY 46 n 47 GLY 46 A TYR 47 n 48 TYR 47 A SER 48 n 49 SER 48 A VAL 49 n 50 VAL 49 A ALA 50 n 51 ALA 50 A LEU 51 n 52 LEU 51 A ALA 52 n 53 ALA 52 A ASN 53 n 54 ASN 53 A GLN 54 n 55 GLN 54 A GLY 55 n 56 GLY 55 A LEU 56 n 57 LEU 56 A PHE 57 n 58 PHE 57 A VAL 58 n 59 VAL 58 A TYR 59 n 60 TYR 59 A ALA 60 n 61 ALA 60 A VAL 61 n 62 VAL 61 A GLU 62 n 63 GLU 62 A PRO 63 n 64 PRO 63 A SER 64 n 65 SER 64 A ILE 65 n 66 ILE 65 A VAL 66 n 67 VAL 66 A MSE 67 n 68 MSE 67 A ARG 68 n 69 ARG 68 A GLN 69 n 70 GLN 69 A GLN 70 n 71 GLN 70 A ALA 71 n 72 ALA 71 A VAL 72 n 73 VAL 72 A VAL 73 n 74 VAL 73 A HIS 74 n 75 HIS 74 A PRO 75 n 76 PRO 75 A GLN 76 n 77 GLN 76 A VAL 77 n 78 VAL 77 A GLU 78 n 79 GLU 78 A TRP 79 n 80 TRP 79 A PHE 80 n 81 PHE 80 A THR 81 n 82 THR 81 A GLY 82 n 83 GLY 82 A TYR 83 n 84 TYR 83 A ALA 84 n 85 ALA 84 A GLU 85 n 86 GLU 85 A ASN 86 n 87 ASN 86 A LEU 87 n 88 LEU 87 A ALA 88 n 89 ALA 88 A LEU 89 n 90 LEU 89 A PRO 90 n 91 PRO 90 A ASP 91 n 92 ASP 91 A LYS 92 n 93 LYS 92 A SER 93 n 94 SER 93 A VAL 94 n 95 VAL 94 A ASP 95 n 96 ASP 95 A GLY 96 n 97 GLY 96 A VAL 97 n 98 VAL 97 A ILE 98 n 99 ILE 98 A SER 99 n 100 SER 99 A ILE 100 n 101 ILE 100 A LEU 101 n 102 LEU 101 A ALA 102 n 103 ALA 102 A ILE 103 n 104 ILE 103 A HIS 104 n 105 HIS 104 A HIS 105 n 106 HIS 105 A PHE 106 n 107 PHE 106 A SER 107 n 108 SER 107 A HIS 108 n 109 HIS 108 A LEU 109 n 110 LEU 109 A GLU 110 n 111 GLU 110 A LYS 111 n 112 LYS 111 A SER 112 n 113 SER 112 A PHE 113 n 114 PHE 113 A GLN 114 n 115 GLN 114 A GLU 115 n 116 GLU 115 A MSE 116 n 117 MSE 116 A GLN 117 n 118 GLN 117 A ARG 118 n 119 ARG 118 A ILE 119 n 120 ILE 119 A ILE 120 n 121 ILE 120 A ARG 121 n 122 ARG 121 A ASP 122 n 123 ASP 122 A GLY 123 n 124 GLY 123 A THR 124 n 125 THR 124 A ILE 125 n 126 ILE 125 A VAL 126 n 127 VAL 126 A LEU 127 n 128 LEU 127 A LEU 128 n 129 LEU 128 A THR 129 n 130 THR 129 A PHE 130 n 131 PHE 130 A ASP 131 n 132 ASP 131 A ILE 132 n 133 ILE 132 A ARG 133 n 134 ARG 133 A LEU 134 n 135 LEU 134 A ALA 135 n 136 ALA 135 A GLN 136 n 137 GLN 136 A ARG 137 n 138 ARG 137 A ILE 138 n 139 ILE 138 A TRP 139 n 140 TRP 139 A LEU 140 n 141 LEU 140 A TYR 141 n 142 TYR 141 A ASP 142 n 143 ASP 142 A TYR 143 n 144 TYR 143 A PHE 144 n 145 PHE 144 A PRO 145 n 146 PRO 145 A PHE 146 n 147 PHE 146 A LEU 147 n 148 LEU 147 A TRP 148 n 149 TRP 148 A GLU 149 n 150 GLU 149 A ASP 150 n 151 ASP 150 A ALA 151 n 152 ALA 151 A LEU 152 n 153 LEU 152 A ARG 153 n 154 ARG 153 A PHE 154 n 155 PHE 154 A LEU 155 n 156 LEU 155 A PRO 156 n 157 PRO 156 A LEU 157 n 158 LEU 157 A ASP 158 n 159 ASP 158 A GLU 159 n 160 GLU 159 A GLN 160 n 161 GLN 160 A ILE 161 n 162 ILE 161 A ASN 162 n 163 ASN 162 A LEU 163 n 164 LEU 163 A LEU 164 n 165 LEU 164 A GLN 165 n 166 GLN 165 A GLU 166 n 167 GLU 166 A ASN 167 n 168 ASN 167 A THR 168 n 169 THR 168 A LYS 169 n 170 LYS 169 A ARG 170 n 171 ARG 170 A ARG 171 n 172 ARG 171 A VAL 172 n 173 VAL 172 A GLU 173 n 174 GLU 173 A ALA 174 n 175 ALA 174 A ILE 175 n 176 ILE 175 A PRO 176 n 177 PRO 176 A PHE 177 n 178 PHE 177 A LEU 178 n 179 LEU 178 A LEU 179 n 180 LEU 179 A PRO 180 n 181 PRO 180 A HIS 181 n 182 HIS 181 A ASP 182 n 183 ASP 182 A LEU 183 n 184 LEU 183 A SER 184 n 185 SER 184 A ASP 185 n 186 ASP 185 A LEU 186 n 187 LEU 186 A PHE 187 n 188 PHE 187 A ALA 188 n 189 ALA 188 A ALA 189 n 190 ALA 189 A ALA 190 n 191 ALA 190 A ALA 191 n 192 ALA 191 A TRP 192 n 193 TRP 192 A ARG 193 n 194 ARG 193 A ARG 194 n 195 ARG 194 A PRO 195 n 196 PRO 195 A GLU 196 n 197 GLU 196 A LEU 197 n 198 LEU 197 A TYR 198 n 199 TYR 198 A LEU 199 n 200 LEU 199 A LYS 200 n 201 LYS 200 A ALA 201 n 202 ALA 201 A GLU 202 n 203 GLU 202 A VAL 203 n 204 VAL 203 A ARG 204 n 205 ARG 204 A ALA 205 n 206 ALA 205 A GLY 206 n 207 GLY 206 A ILE 207 n 208 ILE 207 A SER 208 n 209 SER 208 A SER 209 n 210 SER 209 A PHE 210 n 211 PHE 210 A ALA 211 n 212 ALA 211 A LEU 212 n 213 LEU 212 A ALA 213 n 214 ALA 213 A ASN 214 n 215 ASN 214 A GLN 215 n 216 GLN 215 A ASP 216 n 217 ASP 216 A LEU 217 n 218 LEU 217 A VAL 218 n 219 VAL 218 A GLU 219 n 220 GLU 219 A LYS 220 n 221 LYS 220 A GLY 221 n 222 GLY 221 A LEU 222 n 223 LEU 222 A GLU 223 n 224 GLU 223 A LEU 224 n 225 LEU 224 A LEU 225 n 226 LEU 225 A THR 226 n 227 THR 226 A ALA 227 n 228 ALA 227 A ASP 228 n 229 ASP 228 A LEU 229 n 230 LEU 229 A ASN 230 n 231 ASN 230 A ASN 231 n 232 ASN 231 A GLY 232 n 233 GLY 232 A GLU 233 n 234 GLU 233 A TRP 234 n 235 TRP 234 A ILE 235 n 236 ILE 235 A ARG 236 n 237 ARG 236 A LYS 237 n 238 LYS 237 A TYR 238 n 239 TYR 238 A GLY 239 n 240 GLY 239 A GLU 240 n 241 GLU 240 A ILE 241 n 242 ILE 241 A HIS 242 n 243 HIS 242 A HIS 243 n 244 HIS 243 A LEU 244 n 245 LEU 244 A GLN 245 n 246 GLN 245 A GLU 246 n 247 GLU 246 A ILE 247 n 248 ILE 247 A ASP 248 n 249 ASP 248 A ILE 249 n 250 ILE 249 A GLY 250 n 251 GLY 250 A TYR 251 n 252 TYR 251 A ARG 252 n 253 ARG 252 A PHE 253 n 254 PHE 253 A ILE 254 n 255 ILE 254 A TYR 255 n 256 TYR 255 A THR 256 n 257 THR 256 A THR 257 n 258 THR 257 A LEU 258 n 259 LEU 258 A n 260 259 A n 261 260 A 0.7346 0.1545 0.3869 2.3912 1.9521 2.1391 -0.1113 -0.0292 -0.0441 -0.4589 0.0388 0.0352 -0.2284 -0.1576 0.0725 -0.0409 -0.1336 0.0336 -0.2232 0.0227 -0.2262 refined 46.6820 29.3630 0.3360 X-RAY DIFFRACTION A 12 A 258 X-RAY DIFFRACTION 1 author_and_software_defined_assembly PISA 1 monomeric A MSE 67 SELENOMETHIONINE A MSE 68 MET A MSE 116 SELENOMETHIONINE A MSE 117 MET 1.0000000000 0.0000000000 0.0000000000 0.0000000000 1.0000000000 0.0000000000 0.0000000000 0.0000000000 1.0000000000 1_555 x,y,z identity operation 0.0000000000 0.0000000000 0.0000000000 A O PHE 80 A O PHE 81 A N ALA 60 A N ALA 61 A O VAL 61 A O VAL 62 A N ASP 39 A N ASP 40 A N ALA 38 A N ALA 39 A O ILE 98 A O ILE 99 A N VAL 97 A N VAL 98 A O VAL 126 A O VAL 127 A N LEU 127 A N LEU 128 A O ILE 254 A O ILE 255 A O TYR 255 A O TYR 256 A N GLU 173 A N GLU 174 A N LEU 179 A N LEU 180 A O ILE 247 A O ILE 248 1 A HOH 353 C HOH 1 A CD LYS 33 A CD LYS 34 1 Y 1 A CE LYS 33 A CE LYS 34 1 Y 1 A NZ LYS 33 A NZ LYS 34 1 Y 1 A GLY 0 A GLY 1 1 Y 1 A MSE 1 A MSE 2 1 Y 1 A SER 2 A SER 3 1 Y 1 A ILE 3 A ILE 4 1 Y 1 A TYR 4 A TYR 5 1 Y 1 A ASN 5 A ASN 6 1 Y 1 A SER 6 A SER 7 1 Y 1 A ILE 7 A ILE 8 1 Y 1 A GLY 8 A GLY 9 1 Y 1 A LYS 9 A LYS 10 1 Y 1 A GLN 10 A GLN 11 1 Y 1 A TYR 11 A TYR 12 1 Y 1 A ASP 259 A ASP 260 1 Y 1 A LYS 260 A LYS 261 1 Y 1 3.38 0.50 120.30 123.68 A A A NE CZ NH1 ARG ARG ARG 121 121 121 N 1 -3.29 0.50 120.30 117.01 A A A NE CZ NH2 ARG ARG ARG 121 121 121 N 1 4.69 0.50 120.30 124.99 A A A NE CZ NH1 ARG ARG ARG 133 133 133 N 1 -4.68 0.50 120.30 115.62 A A A NE CZ NH2 ARG ARG ARG 133 133 133 N 1 A ARG 15 -99.94 57.86 1 A ASN 86 -150.54 83.55 1 A ALA 102 -133.40 -34.87 1 A ARG 121 -93.01 -111.23 1 A ALA 191 -89.58 31.63 130.54 70.806 47.24 -1.020 -0.510 0.000 -1.020 0.000 1.530 0.955 0.948 1. HYDROGENS HAVE BEEN ADDED IN THE RIDING POSITIONS. 2. ATOM RECORDS CONTAIN RESIDUAL B FACTORS ONLY. 3. A MET-INHIBITION PROTOCOL WAS USED FOR SELENOMETHIONINE INCORPORATION DURING PROTEIN EXPRESSION. THE OCCUPANCY OF THE SE ATOMS IN THE MSE RESIDUES WAS REDUCED TO 0.75 FOR THE REDUCED SCATTERING POWER DUE TO PARTIAL S-MET INCORPORATION. 4. EDO MOLECULE FROM THE CRYSTALLIZATION SOLUTION IS MODELED. 0.202 0.182 0.184 2.400 29.761 946 18460 5.100 99.760 1.00 0.50 10.455 0.129 RANDOM LIKELY RESIDUAL 1 THROUGHOUT 0.00 SAD 0.217 0.172 0.800 0.800 1.200 MAXIMUM LIKELIHOOD WITH PHASES BABINET MODEL WITH MASK 2.400 29.761 124 2118 4 0 1990 0.017 0.022 2047 0.004 0.020 1371 1.689 1.953 2786 1.422 3.000 3329 4.394 5.000 248 32.885 23.762 101 11.034 15.000 339 16.714 15.000 15 0.096 0.200 315 0.006 0.020 2274 0.002 0.020 432 0.170 0.200 364 0.152 0.200 1419 0.153 0.200 965 0.074 0.200 987 0.127 0.200 108 0.173 0.200 8 0.209 0.200 19 0.075 0.200 9 1.443 2.000 1420 0.179 2.000 498 2.255 4.000 1993 3.653 6.000 912 4.935 8.000 792 0.257 0.235 2.463 72 1269 1341 20 98.310 48.467 2.40 29.761 3EGE 18494 0.109 0.109 1 6.022 8.700 99.800 0.714 2.40 2.46 1.1 7507 1335 0.714 1 5.60 98.70 0.647 2.46 2.53 1.1 8624 1266 0.647 1 6.80 99.90 0.565 2.53 2.60 1.4 11109 1287 0.565 1 8.60 100.00 0.487 2.60 2.68 1.6 11458 1240 0.487 1 9.20 100.00 0.389 2.68 2.77 2.0 11144 1203 0.389 1 9.30 100.00 0.333 2.77 2.87 2.3 10936 1179 0.333 1 9.30 100.00 0.259 2.87 2.98 2.9 10395 1120 0.259 1 9.30 100.00 0.187 2.98 3.10 4.0 10127 1095 0.187 1 9.20 100.00 0.157 3.10 3.24 4.6 9635 1043 0.157 1 9.20 100.00 0.122 3.24 3.39 6.0 9095 988 0.122 1 9.20 100.00 0.095 3.39 3.58 7.6 8849 967 0.095 1 9.20 100.00 0.077 3.58 3.79 9.0 8436 919 0.077 1 9.20 100.00 0.066 3.79 4.06 10.2 7760 854 0.066 1 9.10 100.00 0.064 4.06 4.38 10.1 7111 786 0.064 1 9.00 100.00 0.064 4.38 4.80 9.8 6728 750 0.064 1 9.00 100.00 0.068 4.80 5.37 9.5 6023 680 0.068 1 8.90 100.00 0.069 5.37 6.20 9.4 5279 602 0.069 1 8.80 100.00 0.076 6.20 7.59 8.3 4525 525 0.076 1 8.60 100.00 0.045 7.59 10.73 13.0 3449 414 0.045 1 8.30 100.00 0.044 10.73 29.76 12.0 1788 241 0.044 1 7.40 95.20 refinement Garib N. Murshudov garib@ysbl.york.ac.uk Fortran_77 http://www.ccp4.ac.uk/dist/html/refmac5.html REFMAC program 5.2.0019 refinement P.D. Adams PDAdams@lbl.gov C++ http://www.phenix-online.org/ PHENIX package phasing George M. Sheldrick gsheldr@shelx.uni-ac.gwdg.de Fortran_77 http://shelx.uni-ac.gwdg.de/SHELX/ SHELX package model building D.C. & J.S. Richardson lab molprobity@kinemage.biochem.duke.edu http://kinemage.biochem.duke.edu/molprobity/ MolProbity package 3beta29 data scaling Phil R. Evans pre@mrc-lmb.cam.ac.uk 5/04/2004 Fortran_77 http://www.ccp4.ac.uk/dist/html/scala.html SCALA other 3.2.5 data extraction PDB help@deposit.rcsb.org June 11, 2008 C++ http://sw-tools.pdb.org/apps/PDB_EXTRACT/ PDB_EXTRACT package 3.006 data reduction MOSFLM phasing SHELXD phasing autoSHARP Crystal structure of Putative methyltransferase from antibiotic biosynthesis pathway (YP_324569.1) from ANABAENA VARIABILIS ATCC 29413 at 2.40 A resolution 1 N N 2 N N 3 N N AUTHORS STATE THAT CRYSTAL PACKING ANALYSIS SUGGESTS THE ASSIGNMENT OF A MONOMER AS THE SIGNIFICANT OLIGOMERIZATION STATE. A ASP 18 A ASP 19 HELX_P A ASN 30 A ASN 31 1 1 13 A GLY 45 A GLY 46 HELX_P A ASN 53 A ASN 54 1 2 9 A SER 64 A SER 65 HELX_P A GLN 70 A GLN 71 1 3 7 A ALA 102 A ALA 103 HELX_P A PHE 106 A PHE 107 5 4 5 A HIS 108 A HIS 109 HELX_P A ILE 120 A ILE 121 1 5 13 A ILE 132 A ILE 133 HELX_P A ALA 135 A ALA 136 5 6 4 A ILE 138 A ILE 139 HELX_P A TYR 143 A TYR 144 5 7 6 A PHE 144 A PHE 145 HELX_P A ARG 153 A ARG 154 1 8 10 A PRO 156 A PRO 157 HELX_P A LYS 169 A LYS 170 1 9 14 A ARG 194 A ARG 195 HELX_P A LEU 199 A LEU 200 5 10 6 A LYS 200 A LYS 201 HELX_P A GLY 206 A GLY 207 1 11 7 A ILE 207 A ILE 208 HELX_P A ALA 213 A ALA 214 1 12 7 A ASN 214 A ASN 215 HELX_P A ASN 231 A ASN 232 1 13 18 A GLY 232 A GLY 233 HELX_P A GLY 239 A GLY 240 1 14 8 A GLU 240 A GLU 241 HELX_P A LEU 244 A LEU 245 5 15 5 covale 1.345 both A VAL 66 A C VAL 67 1_555 A MSE 67 A N MSE 68 1_555 covale 1.347 both A MSE 67 A C MSE 68 1_555 A ARG 68 A N ARG 69 1_555 covale 1.332 both A GLU 115 A C GLU 116 1_555 A MSE 116 A N MSE 117 1_555 covale 1.335 both A MSE 116 A C MSE 117 1_555 A GLN 117 A N GLN 118 1_555 TRANSFERASE YP_324569.1, Putative methyltransferase from antibiotic biosynthesis pathway, Structural Genomics, Joint Center for Structural Genomics, JCSG, Protein Structure Initiative, PSI-2, Methyltransferase domain, TRANSFERASE Q3M5R2_ANAVT UNP 1 1 Q3M5R2 MSIYNSIGKQYSQTRVPDIRIVNAIINLLNLPKGSVIADIGAGTGGYSVALANQGLFVYAVEPSIVMRQQAVVHPQVEWF TGYAENLALPDKSVDGVISILAIHHFSHLEKSFQEMQRIIRDGTIVLLTFDIRLAQRIWLYDYFPFLWEDALRFLPLDEQ INLLQENTKRRVEAIPFLLPHDLSDLFAAAAWRRPELYLKAEVRAGISSFALANQDLVEKGLELLTADLNNGEWIRKYGE IHHLQEIDIGYRFIYTTLDK 1 260 3EGE 1 260 Q3M5R2 A 1 2 261 1 expression tag GLY 0 3EGE A Q3M5R2 UNP 1 7 2 parallel parallel parallel parallel anti-parallel anti-parallel anti-parallel A VAL 77 A VAL 78 A PHE 80 A PHE 81 A PHE 57 A PHE 58 A VAL 61 A VAL 62 A VAL 36 A VAL 37 A ILE 40 A ILE 41 A GLY 96 A GLY 97 A ILE 100 A ILE 101 A ILE 125 A ILE 126 A PHE 130 A PHE 131 A TYR 251 A TYR 252 A THR 257 A THR 258 A ARG 171 A ARG 172 A PRO 176 A PRO 177 A LEU 179 A LEU 180 A PRO 180 A PRO 181 A GLU 246 A GLU 247 A ILE 247 A ILE 248 BINDING SITE FOR RESIDUE EDO A 261 A EDO 261 Software 3 A GLY 41 A GLY 42 3 1_555 A GLU 62 A GLU 63 3 1_555 A HOH 279 C HOH 3 1_555 152 P 31 2 1